Adults who received the updated mRNA-1273 COVID-19 vaccine experienced a lower risk for hospitalization compared with NVX-CoV2705 recipients.

A Food and Drug Administration advisory panel on Thursday recommended the approval of Moderna’s mRNA-based flu shot for older adults.

A first-of-its-kind flu shot is one step closer to being available to the public after a Food and Drug Administration (FDA) ...

Preclinical study demonstrates effectiveness of experimental mRNA vaccine against neuroblastoma, reducing tumour size by 70 ...

Moderna, best known for its COVID mRNA vaccine, is developing an investigational mRNA vaccine against the rare Bundibugyo virus species driving the ongoing Ebola outbreak in the Democratic Republic of ...

CHICAGO, June 9 (Reuters) - Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting benefit against the deadly skin cancer melanoma ...

A first-of-its-kind flu shot is one step closer to being available to the public after a Food and Drug Administration (FDA) advisory panel voted Thursday to recommend Moderna’s mRNA-based vaccine for ...

People diagnosed as having multiple sclerosis (MS) often worry about their symptoms intensifying or returning after receiving a live attenuated vaccine, which can cause vaccine hesitancy. But a recent ...

When it comes to Ebola outbreaks, it’s not often we have two pieces of good news in one week. First, we heard there’s new funding of up to US$62 million to fast-track the development of vaccine ...